Biopharma Stock Soaring on Buyout News

Options traders are targeting AVEO at 17 times the intraday average volume

Deputy Editor
Oct 18, 2022 at 3:14 PM
facebook twitter linkedin

Aveo Pharmaceuticals Inc (NASDAQ:AVEO) stock is soaring today, up 40.7% at $14.74 at last glance, after news that South Korean chemical company LG Chem plans to buy the biopharmaceutical name for $15 per share, or roughly $566 million, in an all-cash deal. The acquisition will expand LG's U.S. presence and propel it further into cancer development. 

This bull gap has AVEO at its highest level since March of 2021. The stock was already moving higher before today's bull gap, though, thanks to its 60-day moving average. Year-to-date, the equity is up 215.6%. A short-term drop could be overdue, however, as AVEO's 14-day relative strength index (RSI) of 83.5 sits firmly in "overbought" territory. 

AVEO's options pits are teeming with activity amid the news. So far, 8,145 calls and 1,165 puts have crossed the tape -- 17 times the volume typically seen at this point. The January 2023 15-strike call is the most popular, followed by the October 15 call, with new positions being opened at both. 




Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners